← Open Payments lookup

THOMAS MAMALAKIS: Open Payments

NPI 1346810173 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,290 in 129 payments from 17 companies in 2025. Trend: 2023 $3,481 · 2024 $2,879 · 2025 $2,290

Food & beverage: $2,290
CompanyPaymentsAmount
Alkermes, Inc.14$363
Vanda Pharmaceuticals Inc.11$318
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$251
ABBVIE INC.15$204
Neurocrine BioSciences, Inc.9$181
E.R. Squibb & Sons, L.L.C.10$162
Supernus Pharmaceuticals, Inc.22$142
Collegium Pharmaceutical, Inc.8$137
Axsome Therapeutics, Inc.4$114
Bausch Health US, LLC5$100

Products named: ARISTADA, FANAPT, CAPLYTA, VRAYLAR, INGREZZA, COBENFY, Qelbree, Jornay PM.

Industry payments across VA — which companies pay providers there.